Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 129,659 | 191,586 | 80,077 | 75,574 | 69,374 |
| Marketable Securities | 144,215 | 120,404 | 184,194 | 224,317 | 229,331 |
| Receivables | 7,871 | 7,238 | 4,017 | 4,521 | 2,986 |
| Inventories | 10,342 | 8,437 | 6,831 | 6,152 | 5,365 |
| TOTAL | $295,150 | $329,740 | $276,948 | $313,823 | $309,705 |
| Non-Current Assets | |||||
| PPE Net | 84,670 | 82,648 | 76,825 | 56,138 | 47,465 |
| Investments And Advances | 9,504 | 11,561 | 30,975 | 41,483 | 76,247 |
| Other Non-Current Assets | 6,223 | 6,492 | 6,826 | 7,148 | 7,034 |
| TOTAL | $100,397 | $100,701 | $114,626 | $104,769 | $130,746 |
| Total Assets | $395,547 | $430,441 | $391,574 | $418,592 | $440,451 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,043 | 25,201 | 30,309 | 24,376 | 16,933 |
| TOTAL | $49,064 | $59,366 | $40,118 | $32,654 | $21,477 |
| Non-Current Liabilities | |||||
| Long Term Debt | 205,147 | 200,000 | 200,000 | 200,000 | 200,000 |
| Deferred Revenues | 35,021 | 34,104 | 9,659 | 8,041 | 4,220 |
| TOTAL | $208,640 | $205,460 | $205,475 | $205,150 | $205,815 |
| Total Liabilities | $257,704 | $264,826 | $245,593 | $237,804 | $227,292 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,118 | 46,906 | 44,503 | 44,036 | 44,023 |
| Common Shares | 52 | 46 | 44 | 45 | 44 |
| Retained earnings | -482,921 | -454,185 | -424,075 | -388,382 | -355,566 |
| Other shareholders' equity | -2,219 | -2,756 | -3,172 | -792 | -1,203 |
| TOTAL | $137,843 | $165,615 | $145,981 | $180,788 | $213,159 |
| Total Liabilities And Equity | $395,547 | $430,441 | $391,574 | $418,592 | $440,451 |